medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

1

Version 1

Xiamen University

2
3

Title: A mathematical model for estimating the age-specific transmissibility of a novel

4

coronavirus

5

Running title: Age-specific transmissibility of SARS-CoV-2

6

Ze-Yu Zhao , Yuan-Zhao Zhu , Jing-Wen Xu , Qing-Qing Hu , Zhao Lei , Jia Rui , Xing-Chun

7

Liu , Yao Wang , Meng Yang , Li Luo , Shan-Shan Yu , Jia Li , Ruo-Yun Liu , Fang Xie ,

8

Ying-Ying Su , Yi-Chen Chiang , Yan-Hua Su , Ben-Hua Zhao , Tian-Mu Chen

9

1

1*

1*

1

1

1

1

1

1*

1

2

1

1#

1

1

1

1#

1

1

1#

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health,

10

Xiamen University, Xiamen City 361102, Fujian Province, People‚Äôs Republic of China

11

2

12

84112, Utah, USA

13

*These authors contributed equally to this study.

Division of Public Health, School of Medicine, University of Utah, 201 Presidents Circle, Salt Lake City

14
15

#

16

Tianmu Chen

17

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health,

18

Xiamen University

19

4221-117 South Xiang‚Äôan Road, Xiang‚Äôan District, Xiamen City, Fujian Province, People‚Äôs Republic of

20

China

21

Tel: +86-13661934715

22

Email: chentianmu@xmu.edu.cn, 13698665@qq.com

Correspondence:

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

1

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

23

Yanhua Su

24

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health,

25

Xiamen University,

26

4221-117 South Xiang‚Äôan Road, Xiang‚Äôan District, Xiamen City, Fujian Province, People‚Äôs Republic of

27

China,

28

Email: suyanhua813@xmu.edu.cn

29
30

Benhua Zhao

31

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health,

32

Xiamen University,

33

4221-117 South Xiang‚Äôan Road, Xiang‚Äôan District, Xiamen City, Fujian Province, People‚Äôs Republic of

34

China, Email: benhuazhao@163.com

35
36
37

Abstract

38

Background: A novel coronavirus named as ‚ÄúSARS-CoV-2‚Äù has spread widely in many countries since

39

December 2019, especially in China. This study aimed to quantify the age-specific transmissibility by

40

using a mathematical model.

41

Methods: An age-specific susceptible ‚Äì exposed ‚Äì symptomatic ‚Äì asymptomatic ‚Äì recovered ‚Äì

42

seafood market (SEIARW) model was developed based on two suspected transmission routes (from

43

market to person and person to person). The susceptible people from Wuhan City were divided into

44

different age groups. We used the subscript i and j to represent age group 1 to 4 (i ‚â† j; 1: ‚â§ 14 years; 2:
2

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

45

15-44 years; 3: 45-64 years; 4: ‚â• 65 years) and 1 to 5 (i ‚â† j; 1: ‚â§ 5 years; 2: 6-14 years; 3: 15-24 years; 4:

46

25-59 years; 4: ‚â• 60 years), respectively. Data of reported COVID-19 cases were collected from one

47

published literature from 26 November to 22 December, 2019 in Wuhan City, China. The age-specific

48

transmissibility of the virus was estimated accordingly secondary attack rate (SAR).

49

Results: The age-specific SEIARW model fitted with the reported data well by dividing the population

50

into four age groups (œá = 4.99 ÔÇ¥ 10 , P > 0.999), and five age groups (œá = 4.85 ÔÇ¥ 10 , P > 0.999).

51

Based on the four-age-group SEIARW model, the highest transmissibility occurred from age group 2 to

52

3 (SAR23 = 17.56 per 10 million persons), followed by from age group 3 to 2 (SAR32 = 10.17 per 10

53

million persons). The lowest transmissibility occurred from age group 1 to 2 (SAR12 = 0.002 per 10

54

million persons). Based on the five-age-group SEIARW model, the highest transmissibility occurred

55

from age group 4 to 5 (SAR45 = 12.40 per 10 million persons), followed by from age group 5 to 4 (SAR54

56

= 6.61 per 10 million persons). The lowest transmissibility occurred from age group 3 to 4 (SAR34 =

57

0.0002 per 10 million persons).

58

Conclusions: SARS-CoV-2 has high transmissibility among adults and elder people but low

59

transmissibility among children and young people.

60

Key words: Transmissibility; Novel coronavirus; Mathematical model; Age-specific dynamics

2

-6

2

-6

61

3

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

62

Introduction

63

In December 2019, a series of cases were identified by a novel coronavirus named severe acute

64

respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported by Wuhan City, Hubei Province,

65

China. The disease was named as coronavirus disease 2019 (COVID-19) by the World Health

66

Organization in 11 February 2020. The patients may be related to have contacted with Huanan

67

Seafood Wholesale Market[1], and the virus can continuously transmit from person-to-person with

68

basic reproduction number (R0) of 2.2 (95% confidence interval [CI], 1.4 to 3.9)[2]. Another research

69

estimated that the R0 of SARS-CoV-2 was 2.68 (95% CI, 2.47 to 2.86)[3].

70

Age-related transmissibility of COVID-19 has become a public health concern. The reported cases

71

at the early stage (before 2 January 2020) of the transmission were higher than 18 years old and

72

mainly were on 25-64 years old[1]. A study with 425 patients indicated that the median age was 59

73

years (range, 15 to 89) and reported different case distributions in four age groups: 0 ‚Äì 14, 15 ‚Äì 44, 45

74

‚Äì 64, and ÔÇ≥ 65 years[2]. However, there is not enough epidemiological evidence to classify the age

75

groups in transmission. In this study, we added another age classification scenario according to our

76

previous research on influenza that people were divided into five age groups: 0 ‚Äì 5, 6 ‚Äì 14, 15 ‚Äì 24, 25

77

‚Äì 59, and ÔÇ≥ 60 years[4], to better understand the transmissibility of the disease for different ages.

78

There were several studies focusing on mathematical modelling on COVID-19[2, 3], calculating the

79

R0 by using the serial intervals and intrinsic growth rate[2, 5, 6], or using ordinary differential equations

80

and Markov Chain Monte Carlo methods[3]. We also developed a Bats-Hosts-Reservoir-People (BHRP)

81

transmission network model and simplified the BHRP model as Reservoir-People (RP) transmission

82

network model to calculate the transmissibility of SARS-CoV-2[7]. However, there is no age-specific

83

mathematical model for quantifying the age-specific transmissibility SARS-CoV-2.
4

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

84

In this study, based on the RP model which we developed, we built an age-specific susceptible ‚Äì

85

exposed ‚Äì symptomatic ‚Äì asymptomatic ‚Äì recovered ‚Äì reservoir (SEIARW) model. The age-specific

86

SEIARW model was employed to estimate the age-specific transmissibility of SARS-CoV-2 by fitting

87

the data from 26 November to 23 December, 2019 from published literature[1].

88
89

Methods

90

Data collection

91

The data of COVID-19 were collected in Wuhan City from 26 November, 2019 to 23 December,

92

2019 from a published literature[1], including 29 COVID-19 cases with the onset date and exposure

93

history. The data of total population which were used in our model was from Wuhan City Statistics

94

Bureau. The data of age group proportions, birth rate and death rate in our model was obtained from

95

Wuhan Statistical Yearbook.

96

Study design

97

In this study, people were divided into 4 age groups based on the published literature[1], and 5 age

98

groups based on our previous study[4]. We used the subscript i and j to represent age group 1 to 4 (i ‚â† j;

99

1: 0 ‚Äì 14 years; 2: 15 ‚Äì 44 years; 3: 45 ‚Äì 64 years; 4: ‚â• 65 years) and 1 to 5 (i ‚â† j; 1: 0 ‚Äì 5 years; 2: 6-14

100

years; 3: 15-24 years; 4: 25-59 years; 4: ‚â• 60 years), respectively.

101

Age-specific transmission model

102

Our previous study showed that the SEIARW model could be adopted to simulate the infectious

103

diseases transmitted from reservoir (such as water or food) to people and from person to person[8, 9].

104

In this study, the age-specific SEIARW model was developed based on two transmission routes (form

105

market to person and person to person). In the model, people were divided into five compartments:
5

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

106

susceptible (S), exposed (E), symptomatic (I), asymptomatic (A), recovered (R), and the seafood

107

market were defined as reservoir (W). The definitions of the six compartments were shown in Table 1.

108

The model was based on following assumptions:

109

a) Susceptible individuals become infected by contact with infected/asymptomatic people;

110

b) SARS-CoV-2 can transmit within each age group. The transmission rate of age group i and j are

111
112
113
114
115

Œ≤ii and Œ≤jj respectively.
c) SARS-CoV-2 can be transmitted between different age groups. The transmission rate from age
group i to j is Œ≤ij and from j to i is Œ≤ji.
d) Susceptible people will be infected after contact with seafood market, and the infection rate
coefficient is Œ≤w;

116

e) All the newborn individuals which were assumed as susceptible were added into age group 1.

117

Each age group has a natural mortality rate. We set the natural birth rate is br, and the natural mortality

118

rate is dr;

119

f) The incubation period of exposed person is 1/ ÔÅ∑. The exposed person will become asymptomatic

120

people after a latent period of 1/ ÔÅ∑‚Äô. We describe p (0 ‚â§ p ‚â§ 1) as the proportion of asymptomatic

121

infection. Exposed individuals will become asymptomatic person A with a daily rate of pE, and become

122

symptomatic person with a daily rate of (1-p)E;

123

g) The transmissibility of A is ÔÅ´ times (0 ‚â§ ÔÅ´ ‚â§ 1) of that of I.

124

h) The individuals I and A will become recovered person (R) after an infectious period of 1/Œ≥ and

125
126
127

1/Œ≥‚Äô. A part of I would die due to the infection. We assumed that the case fatality rate was f.
i) I and A individuals can shed pathogens into W with the shedding rate of ŒºI and Œº'A, where Œº and
Œº' are the shedding coefficients;
6

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

128
129
130
131

j) SARS-CoV-2 will remove in the market after a given period (the life time of the virus is 1/Œµ), and
the daily decreasing rate of the pathogen is ŒµW.
The flowchart of the model was shown in Figure 1. The equations of the age-specific SEIARW
model were shown as follows:
ùëëùëÜùëñ
= ùëèùëüùëÅ ‚àí ùõΩùëñùëñ ùëÜùëñ (ùêºùëñ + ÔÅ´ùê¥ùëñ ) ‚àí ùõΩùëóùëñ ùëÜùëñ (ùêºùëó + ÔÅ´ùê¥ùëó ) ‚àí ùõΩùë§ ùëÜùëñ ùëä ‚àí ùëëùëüùëÜùëñ
ùëëùë°
ùëëùê∏ùëñ
= ùõΩùëñùëñ ùëÜùëñ (ùêºùëñ + ÔÅ´ùê¥ùëñ ) + ùõΩùëóùëñ ùëÜùëñ (ùêºùëó + ÔÅ´ùê¥ùëó ) ‚àí (1 ‚àí ùëù)ùúîùê∏ùëñ ‚àí ùëùùúî‚Ä≤ùê∏ùëñ ‚àí ùëëùëüùê∏ùëñ
ùëëùë°
ùëëùêºùëñ
= (1 ‚àí ùëù)ùúîùê∏ùëñ ‚àí ùõæùêºùëñ ‚àí (ùëëùëü + ùëì)ùêºùëñ
ùëëùë°
ùëëùê¥ùëñ
= ùëùùúî‚Ä≤ùê∏ùëñ ‚àí ùõæ ‚Ä≤ ùê¥ùëñ ‚àí ùëëùëüùê¥ùëñ
ùëëùë°
ùëëùëÖùëñ
= ùõæùêºùëñ + ùõæ ‚Ä≤ ùê¥ùëñ ‚àí ùëëùëüùëÖùëñ
ùëëùë°
ùëëùëÜùëó
= ùëèùëüùëÅ ‚àí ùõΩùëóùëó ùëÜùëó (ùêºùëó + ÔÅ´ùê¥ùëó ) ‚àí ùõΩùëóùëñ ùëÜùëó (ùêºùëñ + ÔÅ´ùê¥ùëñ ) ‚àí ùõΩùë§ ùëÜùëó ùëä ‚àí ùëëùëüùëÜùëó
ùëëùë°
ùëëùê∏ùëó
= ùõΩùëóùëó ùëÜùëó (ùêºùëó + ÔÅ´ùê¥ùëó ) + ùõΩùëóùëñ ùëÜùëó (ùêºùëñ + ÔÅ´ùê¥ùëñ ) + ùõΩùë§ ùëÜùëó ùëä ‚àí (1 ‚àí ùëù)ùúîùê∏ùëó ‚àí ùëùùúî‚Ä≤ùê∏ùëó ‚àí ùëëùëüùê∏ùëó
ùëëùë°
ùëëùêºùëó
= (1 ‚àí ùëù)ùúîùê∏ùëó ‚àí ùõæùêºùëó ‚àí (ùëëùëü + ùëì)ùêºùëó
ùëëùë°
ùëëùê¥ùëó
= ùëùùúî‚Ä≤ùê∏ùëó ‚àí ùõæ ‚Ä≤ ùê¥ùëó ‚àí ùëëùëüùê¥ùëó
ùëëùë°
ùëëùëÖùëó
= ùõæùêºùëó + ùõæ ‚Ä≤ ùê¥ùëó ‚àí ùëëùëüùëÖùëó
ùëëùë°
ùëëùëä
= ùúá(ùêºùëñ + ùêºùëó ) + ùúá ‚Ä≤ (ùê¥ùëñ + ùê¥ùëó ) ‚àí ùúÄùëä
ùëëùë°
ùëÅ = ùëÜùëñ + ùê∏ùëñ + ùêºùëñ + ùê¥ùëñ + ùëÖùëñ + ùëÜùëó + ùê∏ùëó + ùêºùëó + ùê¥ùëó + ùëÖùëó

132
133

Since the different dimension of people and the virus, we adopt the following sets to perform the

134

normalization:

135

ùë†ùëñ = ùëÜùëñ /ùëÅ , ùëíùëñ = ùê∏ùëñ /ùëÅ , ùëñùëñ = ùêºùëñ /ùëÅ , ùëéùëñ = ùê¥ùëñ /ùëÅ , ùëüùëñ = ùëÖùëñ /ùëÅ , ùë†ùëó = ùëÜùëó /ùëÅ , ùëíùëó = ùê∏ùëó /ùëÅ , ùëñùëó = ùêºùëó /ùëÅ , ùëéùëó = ùê¥ùëó /ùëÅ ,

136

ùëüùëó = ùëÖùëó /ùëÅ, ùë§ = Œµùëä/ùúáùëÅ, ùúá ‚Ä≤ = ùëêùúá, ùëèùëñùëñ = ùõΩùëñùëñ ùëÅ, ùëèùëñùëó = ùõΩùëñùëó ùëÅ, ùëèùëóùëó = ùõΩùëóùëó ùëÅ, ùëèùëóùëñ = ùõΩùëóùëñ ùëÅ, ùëèùë§ = ùúáùõΩùë§ ùëÅ/ùúÄ.

137
7

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

138
139

In the normalization, parameter c refers to relative shedding coefficients of A compared to I. The
normalized model is expressed as follows:
ùëëùë†ùëñ
= ùëèùëüùëõ ‚àí ùëèùëñùëñ ùë†ùëñ (ùëñùëñ + ÔÅ´ùëéùëñ ) ‚àí ùëèùëóùëñ ùë†ùëñ (ùëñùëó + ÔÅ´ùëéùëó ) ‚àí ùëèùë§ ùë†ùëñ ùë§ ‚àí ùëëùëüùë†ùëñ
ùëëùë°
ùëëùëíùëñ
= ùëèùëñùëñ ùë†ùëñ (ùëñùëñ + ÔÅ´ùëéùëñ ) + ùëèùëóùëñ ùë†ùëñ (ùëñùëó + ÔÅ´ùëéùëó ) ‚àí (1 ‚àí ùëù)ùúîùëíùëñ ‚àí ùëùùúî‚Ä≤ùëíùëñ ‚àí ùëëùëüùëíùëñ
ùëëùë°
ùëëùëñùëñ
= (1 ‚àí ùëù)ùúîùëíùëñ ‚àí ùõæùëñùëñ ‚àí (ùëëùëü + ùëì)ùëñùëñ
ùëëùë°
ùëëùëéùëñ
= ùëùùúî‚Ä≤ùëíùëñ ‚àí ùõæ ‚Ä≤ ùëéùëñ ‚àí ùëëùëüùëéùëñ
ùëëùë°
ùëëùëüùëñ
= ùõæùëñùëñ + ùõæ ‚Ä≤ ùëéùëñ ‚àí ùëëùëüùëüùëñ
ùëëùë°
ùëëùë†ùëó
= ùëèùëüùëõ ‚àí ùëèùëóùëó ùë†ùëó (ùëñùëó + ÔÅ´ùëéùëó ) ‚àí ùëèùëóùëñ ùë†ùëó (ùëñùëñ + ÔÅ´ùëéùëñ ) ‚àí ùëèùë§ ùë†ùëó ùë§ ‚àí ùëëùëüùë†ùëó
ùëëùë°
ùëëùëíùëó
= ùëèùëóùëó ùë†ùëó (ùëñùëó + ÔÅ´ùëéùëó ) + ùëèùëóùëñ ùë†ùëó (ùëñùëñ + ÔÅ´ùëéùëñ ) + ùëèùë§ ùë†ùëó ùë§ ‚àí (1 ‚àí ùëù)ùúîùëíùëó ‚àí ùëùùúî‚Ä≤ùëíùëó ‚àí ùëëùëüùëíùëó
ùëëùë°
ùëëùëñùëó
= (1 ‚àí ùëù)ùúîùëíùëó ‚àí ùõæùëñùëó ‚àí (ùëëùëü + ùëì)ùëñùëó
ùëëùë°
ùëëùëéùëó
= ùëùùúî‚Ä≤ùëíùëó ‚àí ùõæ ‚Ä≤ ùëéùëó ‚àí ùëëùëüùëéùëó
ùëëùë°
ùëëùëüùëó
= ùõæùëñùëó + ùõæ ‚Ä≤ ùëéùëó ‚àí ùëëùëüùëüùëó
ùëëùë°
ùëëùë§
= ùúÄ(ùëñùëñ + ùëñùëó + ùëê(ùëéùëñ + ùëéùëó ) ‚àí ùë§)
ùëëùë°
ùëõ = ùë†ùëñ + ùëíùëñ + ùëóùëñ + ùëéùëñ + ùëüùëñ + ùë†ùëó + ùëíùëó + ùëñùëó + ùëéùëó + ùëüùëó

140

The left side of the equation shows the instantaneous rate of change of S, E, I, A, R and W at time

141

t. The subscript i and j (i ‚â† j) represent age group 1 to 4/5 in the equation, respectively.

142

Parameters estimation

143

The mean incubation period was 5.2 days (95% confidence interval [CI]: 4.1‚Äí7.0) [2]. As reported

144

by Xu et al[10], the median time from exposure to onset of illness (infected) was 4 days (interquartile

145

range 3-5 days). Another study showed that the mean of incubation period was around 5 days and the

146

period falls within the range of 2-14 days [11]. We set the 5-day as the incubation period and the latent

147

period in this study. Thus, ÔÅ∑ = ÔÅ∑‚Äô = 0.2.
8

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

148

Since there was no data on the proportion of asymptomatic infection of the virus, we simulated the

149

baseline value of proportion of 0.5 (p = 0.5). Since there was no evidence about the transmissibility of

150

asymptomatic infection, we assumed that the transmissibility of asymptomatic infection was 0.5 times

151

that of symptomatic infection ( ÔÅ´ = 0.5), which was the similar value as influenza[12]. We assumed that

152

the relative shedding rate of A compared to I was 0.5. Thus, c = 0.5. Since the SARS-CoV-2 is an RNA

153

virus, we assumed that it could be died in the environment in a short time, but it could stay for a longer

154

time (10 days) in the unknown hosts in the market. We set Œµ = 0.1.

155

There is a mean 5-day delay from symptom onset to detection/hospitalization of a case (the cases

156

detected in Thailand and Japan were hospitalized from 3-7 days after onset, respectively) [13-15].

157

Another study showed that the mean time from illness onset to hospital admission (for treatment and/or

158

isolation) was estimated at 3-4 days without truncation and at 5-9 days when right truncated[11]. As

159

reported by Xu et al[10], the median time from onset of illness to first hospital admission was 2 (range

160

from 1-4) days. A study including 45 patients diagnosed before January 1 was estimated to have a

161

mean of 5.8 days (95% CI: 4.3‚Äì7.5) from illness onset to first medical visit[2]. In our model, we set the

162

infectious period of the cases as 6 days. Therefore, Œ≥ = Œ≥‚Äô = 0.1667.

163

According the official report by National Health Commission of the People‚Äôs Republic of China, we

164

collected the data of daily fatality from January 24 to 30 , 2020[16]. Therefore, we set f as 0.02348

165

(range: 0.02198-0.03186). In this study, we set the total population as 11,081,000 so that br = 4.266 ÔÇ¥

166

10 and dr = 3.184 ÔÇ¥ 10 based on the 2018 Wuhan Statistical Yearbook (Table 2).

th

-5

th

-5

167

A two-step curve fitting method was adopted to estimate the parameter bW, bii, bjj, bij, and bji. At the

168

first step, we used the mix-age SEIARW model to fit the data and to estimate the parameter bW and

169

mix-age b (named as bp). At the second step, we used the age-specific SEIARW model to fit the data
9

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

170

and to estimate the parameter bii, bjj, bij, and bji.

171

Quantification of the age-specific transmissibility of SARS-CoV-2

172
173

In the model the age-specific secondary attack rate (SAR) was employed to quantify the
transmissibility of SARS-CoV-2. They were calculated as follows:
ùëÜùê¥ùëÖùëñùëñ = ùõΩùëñùëñ /ùõæ
ùëÜùê¥ùëÖùëñùëó = ùõΩùëñùëó /ùõæ
ùëÜùê¥ùëÖùëóùëñ = ùõΩùëóùëñ /ùõæ
ùëÜùê¥ùëÖùëóùëó = ùõΩùëóùëó /ùõæ

174
175

In the equations, SARii, SARij, SARji, and SARjj refer to the age-specific SAR among age group i,
from age group i to j, from age group j to i, and among age group j, respectively.

176

To quantify the age-specific transmissibility of SARS-CoV-2, we also performed a simulation which

177

was named as ‚Äúknock-out‚Äù simulation in our previous study[17]. In this study, the ‚Äúknock-out‚Äù simulation

178

was defined as cutting off the route of transmission between or within different age groups, and was

179

performed in the following scenarios: A) Œ≤ii = 0; B) Œ≤ji = 0; C) Œ≤ij = 0; D) Œ≤jj = 0; E) control (no cutting off

180

transmission route).

181

Simulation method and statistical analysis

182

Berkeley Madonna 8.3.18 (developed by Robert Macey and George Oster of the University of

183

California at Berkeley. Copyright ¬©1993-2001 Robert I. Macey & George F. Oster) was employed to

184

perform the curve fitting and the simulation. The simulation methods (Runge-Kutta method of order four

185

with tolerance set at 0.001) were the same as the previously published researches [18-24]. The data

186

was analyzed and figured by using Microsoft Office Excel 2010 (Microsoft, Redmond, WA, USA) and

187

GraphPad Prism 7.0 (GraphPad Software, La Jolla, CA). The goodness of fit was judged by coefficient
10

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

188

of determination (R ) and Chi-square (ÔÅ£ ) value calculated by SPSS 21.0 (IBM Corp, Armonk, NY,

189

USA).

190

Sensitivity analysis

2

2

191

Since nine parameters (p, ÔÅ´, c, ÔÅ•, œâ, œâ‚Äô, Œ≥, Œ≥‚Äô and f) in the models were collected from literatures,

192

there might be some uncertainties in our model. Therefore, we performed sensitivity analysis of

193

parameters p, ÔÅ´, c, ÔÅ•, œâ, œâ‚Äô, Œ≥, Œ≥‚Äô and f by splitting them into 1,000 values ranging from 0 ‚Äì 0.9, 0 ‚Äì 1, 0 ‚Äì

194

1, 0 ‚Äì 1, 0.1428 ‚Äì 0.25, 0.1428 ‚Äì 0.25, 0.125 ‚Äì 0.25, 0.125 ‚Äì 0.25, 0.02198 ‚Äì 0.03186, respectively

195

(Table 2).

196
197

Results

198

Epidemiological characteristics and curve fitting of SARS-CoV-2

199

There were 29 COVID-19 cases data collected in Wuhan City from 26 November, 2019 to 23

200

December, 2019, among which 10 cases had a history of the seafood market exposure and 19 cases

201

had no history of the exposure (Figure 2).

202

The mix-age SEIARW model including all age groups fitted the reported data well (œá = 4.77 ÔÇ¥ 10 ,

203

P > 0.999). The results of the curve fitting were shown in Figure 3. The results also showed that the bp

204

= 1.1329 and bW = 0.5255. The age-specific SEIARW model fitted with the reported data well by

205

dividing the population into four age groups (œá = 4.99 ÔÇ¥ 10 , P > 0.999), and five age groups (œá = 4.85

206

ÔÇ¥ 10 , P > 0.999). Thus, the prevalence of COVID-19 in each age group was simulated in Figure 4.

207

Transmissibility of SARS-CoV-2

2

2

-6

-6

2

-6

208

Based on the four-age-group SEIARW model, the highest transmissibility occurred from age group

209

2 to 3 (SAR23 = 17.56 per 10 million persons), followed by from age group 3 to 2 (SAR32 = 10.17 per 10
11

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

210

million persons), from age group 4 to 4 (SAR44 = 6.99 per 10 million persons), and from age group 3 to

211

4 (SAR34 = 5.69 per 10 million persons). The lowest transmissibility occurred from age group 1 to 2

212

(SAR12 = 0.002 per 10 million persons), followed by from age group 3 to 1 (SAR31 = 0.003 per 10 million

213

persons), from age group 4 to 2 (SAR42 = 0.52 per 10 million persons), and from age group 1 to 3

214

(SAR13 = 1.08 per 10 million persons) (Figure 5-A).

215

Based on the five-age-group SEIARW model, the highest transmissibility occurred from age group

216

4 to 5 (SAR45 = 12.40 per 10 million persons), followed by from age group 5 to 4 (SAR54 = 6.61 per 10

217

million persons), from age group 4 to 4 (SAR44 = 5.08 per 10 million persons), and from age group 2 to

218

1 (SAR21 = 4.90 per 10 million persons). The lowest transmissibility occurred from age group 3 to 4

219

(SAR34 = 0.0002 per 10 million persons), followed by from age group 1 to 1 (SAR11 = 0.22 per 10 million

220

persons), from age group 1 to 3 (SAR13 = 1.54 per 10 million persons), and from age group 1 to 2

221

(SAR12 = 1.59 per 10 million persons) (Figure 5-B).

222

The results of the ‚Äúknock-out‚Äù simulation showed that, based on the four-age-group SEIARW

223

model, the scenarios b23 = 0, b32 = 0, and b22 = 0 led to the highest decrease for the number of cases.

224

However, the scenarios b12 = 0, b31 = 0, and b11 = 0 led to the lowest decrease for the number of cases

225

(Figure 6-A). Based on the five-age-group SEIARW model, the scenarios b44 = 0, b45 = 0, and b54 = 0

226

led to the highest decrease for the number of cases. However, the scenarios b12 = 0, b31 = 0, and b11 = 0

227

led to the lowest decrease for the number of cases (Figure 6-B).

228

Sensitivity analysis

229
230

The results of sensitivity analysis showed that the models were slightly sensitive to parameters p,

ÔÅ∑, and Œ≥ but not sensitive to parameters ÔÅ´, c, Œµ, f, ÔÅ∑‚Äô, and Œ≥‚Äô (Figures 7 ‚Äì 8).

231
12

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

232

Discussion

233

This is the first study to develop an age-specific SEIARW model to quantify the transmissibility of

234

COVID-19 among different age groups. The results showed that our model fitted the reported data well,

235

thus has the capability of estimating or predicting? the age-specific transmissibility of the virus.

236

Based on the four-age-group SEIARW model, the highest transmissibility occurred between the

237

age groups 15 ‚Äì 44 years and 45 ‚Äì 64 years, among those ÔÇ≥ 65 years, or from 45 ‚Äì 64 years to ÔÇ≥ 65

238

years. The lowest transmissibility occurred from age group 0-14 years to 15 ‚Äì 44 years, or from 45 ‚Äì 64

239

years to ÔÇ£14 years. Based on the five-age-group SEIARW model, the highest transmissibility occurred

240

between age group 25 ‚Äì 59 years and ÔÇ≥ 60 years, or among 25 ‚Äì 59 years. The lowest transmissibility

241

occurred from age group 15 ‚Äì 24 years to 25 ‚Äì 59 years, or from age group 0-5 years to 6-14 years, or

242

to 15-24 years. The ‚Äúknock-out‚Äù simulation had the similar results. We concluded that the virus was

243

more likely to transmit among older population.

244

These results revealed that SARS-CoV-2 has high transmissibility among adult older than 25 years

245

old or elder people, but has low transmissibility among children or people younger than 14 years.

246

These results were similar to the age-specific transmissibility of influenza A (H1N1)[4]. The age-specific

247

control and prevention interventions are needed.

248

The reasons for the difference of age-specific transmissibility remain unclear. It might be related to

249

the different contact characteristics among different age groups. Adults were more likely to work outside

250

and came into contact with different individuals in work places, buses, subways, or even airplanes.

251

However, children or younger people could stay at home during the outbreak, and they were less likely

252

to get infected, or if they were infected, it was mostly from adults or elder people in the same family.

253

Our findings were based on the parameter estimation and the data from literatures. It is known that
13

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

254

the asymptomatic infection of COVID-19 exists. As reported by Bai et al[25], 1 of 6 cases was

255

asymptomatic infected, with the proportion of asymptomatic of 0.17. As reported by Pan et al[26], 2 of 3

256

cases was asymptomatic infected, with the proportion of asymptomatic of 0.67.There was a research

257

showed that the asymptomatic infection would shed SARS-CoV-2 for 5 days[27]. However, there was

258

not enough evidence to provide the clear epidemiological estimates of the parameters p, ÔÅ´, ÔÅ∑‚Äô, and Œ≥‚Äô

259

which were related to asymptomatic characteristics. Although there was clinical evidence to calculate

260

the parameters related to symptomatic cases such as incubation period, fatality rate, and duration from

261

symptoms onset to diagnosis[1, 2], more epidemiological data are needed to explore the parameters.

262

However, we performed a sensitivity analysis of all the nine parameters from the literatures, and we

263

found that the models was slightly sensitive to parameters p, ÔÅ∑, and Œ≥ but not sensitive to parameters ÔÅ´,

264

c, Œµ, f, ÔÅ∑‚Äô, and Œ≥‚Äô. Therefore, our results might be affected slightly by the parameter estimation.

265

Since we could not obtain the first-hand data, the results of our findings might have some

266

uncertainties. However, our study aimed to develop and provide an age-specific transmission model for

267

the public health department who has the big data to investigate the age-specific transmissibility in

268

real world scenarios.

269

Conclusions

270

By calculating the published data, our model showed that SARS-CoV-2 has a high transmissibility

271

among adults and elder people but low transmissibility among children and young people. Our results

272

provide a mathematical model for investigating the age-specific transmissibility of SARS-CoV-2. More

273

data and studies are needed to estimate the age-specific transmissibility in real world scenarios to

274

better understand the characteristics of the widely spread virus.

275
14

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

276

Abbreviations

277

SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; COVID-19: coronavirus disease 2019;

278

R0: basic reproduction number; CI: confidence interval; BHRP: Bats-Hosts-Reservoir-People; RP:

279

Reservoir-People; SEIARW: susceptible ‚Äì exposed ‚Äì symptomatic ‚Äì asymptomatic ‚Äì recovered ‚Äì

280

reservoir; SAR: secondary attack rate; R : coefficient of determination.

281

Acknowledgements

282

Not applicable.

283

Funding

284

This study was partly supported by Xiamen New Coronavirus Prevention and Control Emergency

285

Tackling Special Topic Program (No: 3502Z2020YJ03) and the XMU Training Program of Innovation

286

and Enterpreneurship for Undergraduates (No: 2019Y0805, 2019Y1497, 2019Y1499, 2019Y1500, and

287

2019Y1501).

288

Availability of data and materials

289

Not applicable.

290

Authors‚Äô contributions

291

TMC and ZYZ designed research; TMC, YHS, BHZ, and ZYZ conceived the experiments, TMC, ZYZ,

292

YZZ, JWX, ZL, JR, XCL, YW, MY, LL, SSY, JL, RYL, FX, YYS, and YCC conducted the experiments

293

and analyzed the results; TMC, ZYZ, and QQH wrote the manuscript. All authors read and approved

294

the final manuscript.

295

Competing interests

296

The authors declare that they have no competing interests.

297

Consent for publication

2

15

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

298

Not applicable.

299

Ethics approval and consent to participate

300

Not applicable.

301
302
303
304

References

305

1.

306
307

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with
2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.

2.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan,

308

China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; doi:

309

10.1056/NEJMoa2001316.

310

3.

Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and

311

international spread of the 2019-nCoV outbreak originating in Wuhan, China: a

312

modelling study. Lancet. 2020; doi: 10.1016/S0140-6736(20)30260-9.

313

4.

Liu R, Leung RK, Chen T, Zhang X, Chen F, Chen S, et al. The Effectiveness of Age-Specific

314

Isolation Policies on Epidemics of Influenza A (H1N1) in a Large City in Central South

315

China. PloS one. 2015; 10:e0132588.

316

5.

Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. Preliminary estimation of the basic

317

reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A

318

data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92:214-7.

319

6.

Zhao S, Musa SS, Lin Q, Ran J, Yang G, Wang W, et al. Estimating the Unreported Number
16

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

320

of Novel Coronavirus (2019-nCoV) Cases in China in the First Half of January 2020: A

321

Data-Driven Modelling Analysis of the Early Outbreak. J Clin Med. 2020; doi:

322

10.3390/jcm9020388.

323

7.

324
325

phase-based transmissibility of a novel coronavirus. Infect Dis Poverty. 2020; 9:24.
8.

326
327

Chen T, Leung RK, Zhou Z, Liu R, Zhang X, Zhang L. Investigation of key interventions for
shigellosis outbreak control in China. PloS one. 2014; 9:e95006.

9.

328
329

Chen T, Rui J, Wang Q, Zhao Z, Cui J-A, Yin L. A mathematical model for simulating the

Chen T, Gu H, Leung RK, Liu R, Chen Q, Wu Y, et al. Evidence-Based interventions of
Norovirus outbreaks in China. BMC Public Health. 2016; 16:1072.

10.

Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of

330

patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan,

331

China: retrospective case series. BMJ. 2020; 368:m606.

332

11.

Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR. Incubation Period and Other

333

Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right

334

Truncation: A Statistical Analysis of Publicly Available Case Data. J Clin Med. 2020; 9. pii:

335

E538.

336

12.

337
338

Longini IM, Jr., Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, et al.
Containing pandemic influenza at the source. Science. 2005; 309:1083-7.

13.

Japan MoH. Development of patients with pneumonia associated with new coronavirus.

339

Ministry

340

https://www.mhlw.go.jp/stf/newpage_08906.html.

341

14.

of

Health

Japan.

cited

16

Jan

2020:

Available:

World Health Organization. Novel Coronavirus ‚Äì Thailand (ex-China). World Health
17

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

342

Organization.

343

https://www.who.int/csr/don/14-january-2020-novel-coronavirus-thailand/en/.

344

15.

cited

January

20,

2020:

Available:

World Health Organization. Novel Coronavirus ‚Äì Japan (ex-China). World Health

345

Organization.

346

https://www.who.int/csr/don/17-january-2020-novel-coronavirus-japan-ex-china/en/.

347

16.

cited

January

31st.

349

http://www.nhc.gov.cn/xcs/xxgzbd/gzbd_index.shtml.
17.

2020:

Available:

China NHCotPsRo. Update on the novel coronavirus pneumonia outbreak at 24 January

348

350

20,

Cited

on

Febuary

23,

2020:Available:

Zhao Z, Chen Q, Zhao B, Hannah MN, Wang N, Wang Y, et al. The relative transmissibility

351

of shigellosis among male and female individuals in Hubei Province, China: a modelling

352

study. bioRxiv. 2019; 677088.

353

18.

354
355

Chen T, Ka-Kit Leung R, Liu R, Chen F, Zhang X, Zhao J, et al. Risk of imported Ebola virus
disease in China. Travel Med Infect Dis. 2014;12:650-8.

19.

Chen T, Huang Y, Liu R, Xie Z, Chen S, Hu G. Evaluating the effects of common control

356

measures for influenza A (H1N1) outbreak at school in China: A modeling study. PloS

357

one. 2017; 12:e0177672.

358

20.

359
360

Chen S, Yang D, Liu R, Zhao J, Yang K, Chen T. Estimating the transmissibility of hand,
foot, and mouth disease by a dynamic model. Public Health. 2019; 174:42-8.

21.

Huang Z, Wang M, Qiu L, Wang N, Zhao Z, Rui J, et al. Seasonality of the transmissibility of

361

hand, foot and mouth disease: a modelling study in Xiamen City, China. Epidemiol Infect.

362

2019;147:e327.

363

22.

Liao Y, He Y, Lu Y, Yang H, Su Y, Chiang Y-C, et al. Relative transmissibility of hand, foot
18

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

364
365

and mouth disease from male to female individuals. Epidemiol Infect. 2019;147:e284.
23.

Yi B, Chen Y, Ma X, Rui J, Cui JA, Wang H, et al. Incidence dynamics and investigation of

366

key interventions in a dengue outbreak in Ningbo City, China. PLoS Negl Trop Dis.

367

2019;13:e0007659.

368

24.

369
370

conjunctivitis in small-scale outbreaks in Hunan Province, China. Sci Rep. 2020; 10:119.
25.

371
372

Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed Asymptomatic Carrier
Transmission of COVID-19. JAMA. 2020; doi: 10.1001/jama.2020.2565..

26.

373
374

Zhang S, Hu Q, Deng Z, Hu S, Liu F, Yu S, et al. Transmissibility of acute haemorrhagic

Pan X, Chen D, Xia Y, Wu X, Li T, Ou X, et al. Asymptomatic cases in a family cluster with
SARS-CoV-2 infection. Lancet Infect Dis. 2020; doi: 10.1016/S1473-3099(20)30114-6.

27.

Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 Viral Load in Upper

375

Respiratory

376

10.1056/NEJMc2001737.

Specimens

of

Infected

Patients.

N

Engl

J

Med.

2020;

doi:

377
378
379
380

19

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

381

Figures

382

383
384

Figure 1. Flowchart of the age-specific SEIARW model

385

20

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

386
387

Figure 2. Epidemic curve of collected data of reported COVID-19 cases in Wuhan City from 26

388

November, 2019 to 23 December, 2019

389

21

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

390
391

Figure 3. Results of curve fitting of the mix age SEIARW model to the reported data

392

22

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

393
394

Figure 4. Results of curve fitting of the age-specific SEIARW model to the reported data. A-a:

395

curve fitting based on four age groups; A-b: the simulated prevalence by the age-specific SEIARW

396

model based on the four age groups; B-a: curve fitting based on five age groups; B-b: the simulated

397

prevalence by the age-specific SEIARW model based on the five age groups.

398

23

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

399
400

Figure 5. SAR simulated from the age-specific SEIARW model. A: SAR based on four age groups;

401

B: SAR based on five age groups.

402

24

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

403
404

Figure 6. Results of the ‚Äúknock-out‚Äù simulation from the age-specific SEIARW model. A: results

405

based on four age groups; B: results based on five age groups.

406

25

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

407
408

Figure 7. Results of sensitivity analysis of p, ÔÅ´, c, and Œµ. A: sensitivity analysis of p; B: sensitivity

409

analysis of ÔÅ´; C: sensitivity analysis of c; D: sensitivity analysis of Œµ.

410

26

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

411
412

Figure 8. Results of sensitivity analysis of œâ, œâ‚Äô, Œ≥, Œ≥‚Äô and f. A: sensitivity analysis of œâ; B:

413

sensitivity analysis of œâ‚Äô; C: sensitivity analysis of Œ≥; D: sensitivity analysis of Œ≥‚Äô; F: sensitivity analysis of

414

f.

415
416

27

medRxiv preprint doi: https://doi.org/10.1101/2020.03.05.20031849; this version posted March 8, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

417

Tables

418

Table 1. Variables in the age-specific SEIARW model
Variables

Description

Unit

Si

Susceptible individuals density of age group i

Individuals¬∑km

-2

Sj

Susceptible individuals density of age group j

Individuals¬∑km

-2

Ei

Exposed individuals density of age group i

Individuals¬∑km

-2

Ej

Exposed individuals density of age group j

Individuals¬∑km

-2

Ii

Infectious individuals density age group i

Individuals¬∑km

-2

Ij

Infectious individuals density age group j

Individuals¬∑km

-2

Ai

Asymptomatic individuals density age group i

Individuals¬∑km

-2

Aj

Asymptomatic individuals density age group j

Individuals¬∑km

-2

Ri

Recovered individuals density age group i

Individuals¬∑km

-2

Rj

Recovered individuals density age group j

Individuals¬∑km

-2

W

Pathogen concentration in the seafood market

Viruses¬∑mL

N

Total number of population density

Individuals¬∑km

-3

-2

419
420

28

421

Table 2. Description and values of parameters in the age-specific SEIARW model
Parameter

Description

Unit

Œ≤ii

*

Transmission relative rate among age group i

Individuals ¬∑days

-1

bii

*

Scaled i-to-i contact rate

days

Œ≤ij

*

Transmission relative rate from age group i to j

Individuals ¬∑days

bij

*

Scaled i-to-j contact rate

days

Œ≤ji

*

Transmission relative rate from age group j to i

Individuals ¬∑days

bji

*

Scaled j-to-i contact rate

days

Œ≤jj

*

Transmission relative rate among age group i

Individuals ¬∑days

bjj

*

Scaled j-to-j contact rate

days

Œ≤w

Seafood market contact rate

mL ¬∑cells ¬∑days

bw

Scaled market-to-person contact rate

days

-1

-1

-1

-1

-1

-1

-1

-1

-1

-1

-1

-3

-1

-1

-1

Value

Range

Method

Ôºç

Ôºç

Ôºç

Ôºç

‚â•0

Curve fitting

Ôºç

Ôºç

Ôºç

Ôºç

‚â•0

Curve fitting

Ôºç

Ôºç

Ôºç

Ôºç

‚â•0

Curve fitting

Ôºç

Ôºç

Ôºç

Ôºç

‚â•0

Curve fitting

Ôºç

Ôºç

Ôºç

0.9122

‚â•0

Curve fitting

0.5

0-1

Reference [12]

Relative transmissibility rate of asymptomatic to

ÔÅ´

1
symptomatic individuals

29

p

Proportion of the asymptomatic

1

0.5

0-1

Reference [12]
References [2, 10,

œâ

Incubation relative rate

days

-1

0.2

0.1428-0.25
11]
References [2, 10,

œâ'

Latent relative rate

days

-1

0.2

0.1428-0.25
11]
References [2, 10,

Œ≥

Removed rate of the infectious

days

-1

0.1667

0.125-0.25
11, 13-15]
References [2, 10,

Œ≥'

Removed rate of the asymptomatic

days

-1

0.1667

0.125-0.25
11, 13-15]

f

Fatality of the disease

1

Œµ

Pathogen lifetime relative rate

days

-1

0.02348

0.02198-0.03186

References [12]

0.1

Ôºç

Assumption

Person‚Äìto-reservoir contact rate (‚Äò‚Äòshedding‚Äô‚Äô
Œº

-3

-1

2

-1

Ôºç

Ôºç

Ôºç

-3

-1

2

-1

Ôºç

Ôºç

Ôºç

cells¬∑mL ¬∑day ¬∑km ¬∑individuals
by Infectious)

Œº'

Person‚Äìto-reservoir contact rate (‚Äò‚Äòshedding‚Äô‚Äô by

cells¬∑mL ¬∑day ¬∑km ¬∑individuals

30

Asymptomatic)
Relative

shedding

rate

of

asymptomatic

c

1

0.5

1

0.00004266

0-1

Reference [12]

compared to infectious
Wuhan Statistical
br

Birth rate of the population

Ôºç
Yearbook
Wuhan Statistical

dr

Death rate of the population

1

0.00003184

Ôºç
Yearbook

422

*: i and j represent age group 1 to 4/5, respectively, and i ‚â† j

423
424

31

